NCT04202536 - Switching From Tenofovir Disoproxil Fumarate to Besifovir Dipivoxil Maleate | Biotech Hunter

Enrollment

152

Participants

Timeline

Start Date

May 29, 2019

Primary Completion Date

June 30, 2021

Study Completion Date

October 31, 2021

Conditions

Hepatitis BBesifovir Dipivoxil MaleateTenofovir Disoproxil Fumarate

Interventions

DRUG

Besifovir Dipivoxil Maleate

Besifovir 150 mg q.d. + L-carnitine (L-Carn Tab. 330 mg) 660 mg q.d. Other Name: Besifovir®

DRUG

Tenofovir disoproxil fumarate(TDF)

300 mg tablet administered orally once daily Other Name: VIREAD®

Trial Locations (1)

RECRUITING

Korea University Medical Center, Ansan